共 6 条
[1]
Impugning the integrity of medical science - The adverse effects of industry influence
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2008, 299 (15)
:1833-1835
[2]
Ensuring Integrity in Industry-Sponsored Research Primum Non Nocere, Revisited
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2010, 303 (12)
:1196-1198
[3]
Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2005, 294 (01)
:110-111
[4]
Keiding N, 2010, BIOSTATISTICS, V11, P376, DOI 10.1093/biostatistics/kxq033
[5]
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment - A case study based on documents from rofecoxib litigation
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2008, 299 (15)
:1813-1817
[6]
Extra scrutiny for industry funded trials - JAMA's demand for an additional hurdle is unfair - and absurd
[J].
BRITISH MEDICAL JOURNAL,
2005, 331 (7529)
:1350-1351